SHS Capital and co-investors sell SELFAPY to MEDICE

Tübin­gen — Selfapy GmbH, a digi­tal health pioneer for mental illness, has been acqui­red by the MEDICE Health Family, the Euro­pean market leader in the treat­ment of ADHD. As part of the tran­sac­tion, inves­tors SHS Capi­tal, Think.Health Ventures, IBB Ventures and HTGF sold their shares. 

Selfapy’s CE-certi­­fied medi­cal devices offer flexi­ble and quickly acces­si­ble online therapy programs for people with mental illnesses such as depres­sion, gene­ra­li­zed anxiety disor­der, buli­mia nervosa, binge eating disor­der and chro­nic pain. The programs are available as an app on smart­phones and tablets and can be prescri­bed by doctors or psychotherapists. 

The acqui­si­tion of Selfapy is another important step for the MEDICE Health Family on its way from a pure phar­maceu­ti­cal manu­fac­tu­rer to a provi­der of clini­cally vali­da­ted, multi­mo­dal health­care solu­ti­ons combi­ning phar­maceu­ti­cals, digi­tal solu­ti­ons and nutri­tio­nal concepts.

“We want to take even more compre­hen­sive care of pati­ents while also keeping an eye on current chal­lenges in the health­care system. This is why we have been expan­ding our strong core in the phar­maceu­ti­cal busi­ness for seve­ral years to include deve­lo­p­ments in the field of digi­tal health­care solu­ti­ons,” says Dr. Katja Pütter-Ammer, Mana­ging Part­ner of MEDICE, explai­ning the stra­tegy of the family-run company.

“Selfapy alre­ady accounts for 20% of all perma­nently listed DiGAs in the mental health sector. By joining forces with MEDICE and their strong ties to doctors and psycho­the­ra­pists, we can now work even more speci­fi­cally on reali­zing our vision so that no one with a mental illness has to wait for help. Toge­ther, we want to take digi­tal care to a new level and reach even more people faster and more effec­tively,” says Selfapy Mana­ging Direc­tor and CEO Adham Kassab.

Dr. Corne­lius Maas, Part­ner at SHS Capi­tal, who served as Chair­man of the Advi­sory Board at Selfapy for many years, comm­ents on the tran­sac­tion as follows: “We are deligh­ted that we have been able to firmly estab­lish Selfapy with its digi­tal health appli­ca­ti­ons as an inno­va­tive form of treat­ment in the German health­care market in recent years. With MEDICE as a stra­te­gic buyer, we have found the perfect part­ner for the next deve­lo­p­ment phase of Selfapy and wish both compa­nies contin­ued success together.”

About SHS

“Buil­ding Euro­pean Health­care Cham­pi­ons” is the guiding prin­ci­ple of the Tübin­­gen-based inves­tor SHS Capi­tal. With this in mind, the inves­tor specia­li­zing in health­care invest­ments finan­ces and deve­lops its port­fo­lio compa­nies. Since its foun­da­tion in 1993, the focus of its invest­ments has been on expan­sion finan­cing, share­hol­der chan­ges and succes­sion situations. 

www.shs-capital.eu